| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/28/2023 | Trevi Therapeutics, Inc. | TRVI | Grant | Nonstatutory Stock Option (right to buy) | 30k | $2.27 | $68.1k | | 06/28/2023 |
| 11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 14k | $2.17 | $30.4k | | 11/30/2022 |
| 11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 12k | $4.72 | $56.6k | | 11/30/2022 |
| 11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 10k | $3.02 | $30.2k | | 11/30/2022 |
| 11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 10k | $6.90 | $69k | | 11/30/2022 |
| 11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 10k | $4.25 | $42.5k | | 11/30/2022 |
| 11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 8k | $7.75 | $62k | | 11/30/2022 |
| 11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 16k | $15.13 | $242.1k | | 11/30/2022 |
| 06/23/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Nonstatutory Stock Option (right to buy) | 20k | $2.27 | $45.4k | | 06/23/2022 |
| 06/23/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Nonstatutory Stock Option (right to buy) | 20k | $2.27 | $45.4k | | 06/23/2022 |
| 11/30/2021 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Grant | Stock Option (right to buy) | 14k | $2.17 | $30.4k | | 11/30/2021 |
| 06/16/2021 | Trevi Therapeutics, Inc. | TRVI | Grant | Nonstatutory Stock Option (right to buy) | 20k | $2.25 | $45k | | 06/16/2021 |
| 12/16/2020 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Grant | Stock Option (right to buy) | 12k | $4.72 | $56.6k | | 12/16/2020 |
| 06/11/2020 | Trevi Therapeutics, Inc. | TRVI | Grant | Nonstatutory Stock Option (right to buy) | 14.2k | $4.10 | $58.3k | | 06/11/2020 |
| 12/04/2019 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Grant | Stock Option (right to buy) | 10k | $3.02 | $30.2k | | 12/04/2019 |
| 06/12/2019 | Vaxart, Inc. | VXRT | Grant | Stock Option (right to buy) | 12.7k | $0.68 | $8.6k | | 06/12/2019 |
| 06/12/2019 | Vaxart, Inc. | VXRT | Grant | Stock Option (right to buy) | 9k | $0.68 | $6.1k | | 06/12/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Common Stock | 21k | $0.00 | $0 | | 05/09/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Purchase | Common Stock | 5k | $10.00 | $50k | | 05/09/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Series A Preferred Stock | 108k | $0.00 | $0 | | 05/09/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Series C Preferred Stock | 47.8k | $0.00 | $0 | | 05/09/2019 |
| 05/07/2019 | Trevi Therapeutics, Inc. | TRVI | Grant | Stock Option (right to buy) | 23.7k | $10.00 | $236.8k | | 05/07/2019 |
| 11/15/2018 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Grant | Stock Option (right to buy) | 10k | $6.90 | $69k | | 11/15/2018 |
| 07/25/2018 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Grant | Stock Option (right to buy) | 8k | $4.25 | $34k | | 07/25/2018 |
| 07/25/2018 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Grant | Stock Option (right to buy) | 10k | $4.25 | $42.5k | | 07/25/2018 |
| 12/11/2017 | Ocera Therapeutics, Inc. | OCRX | Disposition | Stock Option (Right to Buy) | 10k | $7.84 | $78.4k | | 12/11/2017 |
| 12/11/2017 | Ocera Therapeutics, Inc. | OCRX | Disposition | Common Stock | 12.5k | $1.52 | $19k | | 12/11/2017 |
| 12/11/2017 | Ocera Therapeutics, Inc. | OCRX | Disposition | Stock Option (Right to Buy) | 12.5k | $2.26 | $28.2k | | 12/11/2017 |
| 12/11/2017 | Ocera Therapeutics, Inc. | OCRX | Disposition | Stock Option (Right to Buy) | 20k | $7.85 | $157k | | 12/11/2017 |
| 12/11/2017 | Ocera Therapeutics, Inc. | OCRX | Disposition | Stock Option (Right to Buy) | 10k | $3.76 | $37.6k | | 12/11/2017 |
| 12/11/2017 | Ocera Therapeutics, Inc. | OCRX | Disposition | Stock Option (Right to Buy) | 2.1k | $48.00 | $100k | | 12/11/2017 |
| 12/11/2017 | Ocera Therapeutics, Inc. | OCRX | Disposition | Stock Option (Right to Buy) | 2.7k | $50.88 | $134.9k | | 12/11/2017 |
| 06/20/2017 | Ocera Therapeutics, Inc. | OCRX | Grant | Common Stock | 12.5k | $0.00 | $0 | | 06/20/2017 |
| 12/22/2016 | NOVELION THERAPEUTICS INC. | NVLNF | Grant | Stock Option (Right to Buy) | 9.6k | $0.00 | $0 | | 12/22/2016 |
| 06/14/2016 | Ocera Therapeutics, Inc. | OCRX | Grant | | 12.5k | $2.26 | $28.2k | | 06/14/2016 |
|